No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the innovation and commercialization of therapeutic solutions for various kidney-related disorders. The company's primary offering, Sibnayal, targets both distal renal tubular acidosis and cystinuria. Established in 2007, Advicenne S.A. maintains its principal offices in Paris, France.
www.advicenne.comNo one on the platform currently holds ALDVI.PA.
No tracked institution reports a position in ALDVI.PA as of their last filing.
No one on the platform has traded ALDVI.PA yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $7M | +15.2% | $-0.47 | $-0.47–$-0.47 | — | 1 |
| 2027 | $8M | +21.2% | $-0.44 | $-0.44–$-0.44 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ALDVI.PAAdvicenne S.A. | $0.74 | -12.82% | $11M | — |
| AELIS.PAAelis Farma S.A. | $0.96 | +1.05% | $13M | — |
| ALCOX.PANicox S.A. | $0.33 | -1.04% | $32M | — |
| ALGEN.PAgenOway S.A. | $2.38 | -2.46% | $29M | — |
| ALIKO.PAIkonisys S.A. | $1.40 | +0.00% | $22M | — |
| ALNFL.PANFL Biosciences S.A. | $0.81 | -1.46% | $10M | — |
| ALTHX.PATHX Pharma | $3.24 | -2.99% | $47M | — |
Source: Financial Modeling Prep · peers by sector/industry